At the more speculative end of the spectrum are metabolically healthy adults using low-dose GLP-1s for longevity, inflammation control, cognitive performance, or broader optimization goals
Patients taking semaglutide should contact their healthcare provider if they develop new or worsening symptoms suggestive of restless leg syndrome, particularly if these symptoms significantly impact sleep quality or daily functioning
And in a Blue Cross Blue Shield Association white paper posted last summer, the number was even lower, 15%
After matching, 32,266 individuals were included in the main analysis (16,133 in each group)
In diabetes care, glucagon is known for raising blood glucose during hypoglycemia
What Does the Research Say About GLP-1s and PMOS